Takhzyro now available in Newfoundland & Labrador
daphnecanada2021-03-19T12:14:53-06:00We love sharing amazing news, and now we have even more to love! On March 17th, 2021, lanadelumab (TAKHZYRO), a subcutaneous monoclonal antibody inhibitor of plasma kallikrein, was added to the Newfoundland & Labrador Prescription